期刊簡介預(yù)計審稿時間： 8 Weeks

Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.

Vision: Our vision is to be the premier peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation.

Mission: The mission of Neurology Neuroimmunology & Neuroinflammation is to provide neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research.

We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.

神經(jīng)病學：《神經(jīng)免疫學與神經(jīng)炎癥》是美國神經(jīng)病學學會的官方期刊。

愿景：我們的愿景是成為神經(jīng)免疫學和神經(jīng)炎癥領(lǐng)域?qū)＜业氖浊恢傅耐性u審期刊。

使命：《神經(jīng)病學：神經(jīng)免疫學與神經(jīng)炎癥》的使命是為神經(jīng)病學家和具有轉(zhuǎn)化思維的科學家提供同行評審的文章、社論和評論，以加強患者護理、教育以及臨床和轉(zhuǎn)化研究。

我們發(fā)表經(jīng)過嚴格同行評審的開放獲取原創(chuàng)研究報告和神經(jīng)免疫學與神經(jīng)炎癥主題的深入評論，影響各種神經(jīng)系統(tǒng)疾病，包括（但不限于）：阿爾茨海默病、帕金森病、ALS、tau 蛋白病和中風；多發(fā)性硬化癥和 NMO；炎癥性周圍神經(jīng)和肌肉疾病、格林-巴利綜合征和重癥肌無力；神經(jīng)系統(tǒng)感染；副腫瘤綜合征、非感染性腦炎和其他抗體介導(dǎo)的疾?。灰约熬窈蜕窠?jīng)發(fā)育障礙。還將介紹臨床試驗、指導(dǎo)性病例報告和小型病例系列。

《Neurology-neuroimmunology & Neuroinflammation》(神經(jīng)病學-神經(jīng)免疫學和神經(jīng)炎癥)編輯部通訊方式為TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。